These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10493441)

  • 1. Thick malignant melanoma is a long-term problem.
    Asquith PR; Barnett JM; Lockett BK
    N Z Med J; 1999 Aug; 112(1094):313-6. PubMed ID: 10493441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thick melanoma: the challenge persists.
    Murray CS; Stockton DL; Doherty VR
    Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary malignant melanoma of skin in four regions of New Zealand.
    Cooke K; McNoe B; Hursthouse M; Taylor R
    N Z Med J; 1992 Aug; 105(939):303-6. PubMed ID: 1501812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
    Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
    Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of thick melanomas in the United States: beware of the nodular subtype.
    Demierre MF; Chung C; Miller DR; Geller AC
    Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year audit of melanoma in a central England population.
    Hardwicke J; Brunt AM; Rylands G; Rayatt S
    Acta Derm Venereol; 2011 Jun; 91(4):440-3. PubMed ID: 21336477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in melanoma epidemiology suggest three different types of melanoma.
    Lipsker D; Engel F; Cribier B; Velten M; Hedelin G
    Br J Dermatol; 2007 Aug; 157(2):338-43. PubMed ID: 17596175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The control of melanoma in New Zealand.
    Sneyd M; Cox B
    N Z Med J; 2006 Sep; 119(1242):U2169. PubMed ID: 16998570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dubreuilh melanoma: and epidemiologic and prognostic study].
    Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
    Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma incidence in Tauranga 1980-9.
    Brown L; Palmer PH
    N Z Med J; 1991 Mar; 104(908):109-11. PubMed ID: 2011289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thick melanoma: the problem continues.
    Tejera-Vaquerizo A; Mendiola-Fernández M; Fernández-Orland A; Herrera-Ceballos E
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):575-9. PubMed ID: 18081751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
    Crocetti E; Carli P
    Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and thickness of cutaneous malignant melanoma in New Zealand 1994-2004.
    Richardson A; Fletcher L; Sneyd M; Cox B; Reeder AI
    N Z Med J; 2008 Aug; 121(1279):18-26. PubMed ID: 18709044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
    Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980.
    van der Spek-Keijser LM; van der Rhee HJ; Tóth G; Van Westering R; Bruijn JA; Coebergh JW
    Br J Dermatol; 1997 Apr; 136(4):565-71. PubMed ID: 9155959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extremely high levels of melanoma in Tauranga, New Zealand: possible causes and comparisons with Australia and the northern hemisphere.
    Salmon PJ; Chan WC; Griffin J; McKenzie R; Rademaker M
    Australas J Dermatol; 2007 Nov; 48(4):208-16. PubMed ID: 17956477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
    McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
    Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective epidemiological study on cutaneous melanomas in the Vendée area].
    Brisson C; Reynaud-Hautin C; Bure E; Chatal M; Hadet-Riegert M; Rafstedt P; Humeau S; Kerangueven J; Leroux E; Legroux J; Martin MP; Nogues M; Remond L; Ottavy N; Thebaud Y; Patarin M; Clement A; Proux M
    Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1121-4. PubMed ID: 14724514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.
    Livestro DP; Kaine EM; Michaelson JS; Mihm MC; Haluska FG; Muzikansky A; Sober AJ; Tanabe KK
    Cancer; 2007 Aug; 110(3):614-24. PubMed ID: 17577228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.